✦ LIBER ✦

De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation

✍ Scribed by Kazutoyo Morita; Akinobu Taketomi; Yuji Soejima; Toru Ikegami; Takasuke Fukuhara; Tomohiro Iguchi; Shigeyuki Nagata; Keishi Sugimachi; Tomonobu Gion; Ken Shirabe; Yoshihiko Maehara

Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 276 KB
Volume: 15
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.21894

No coin nor oath required. For personal study only.

✦ Synopsis

The occurrence of de novo hepatocellular carcinoma (HCC) after liver transplantation (LT) for advanced HCCs has been extremely limited. In this article, a case of de novo HCC in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation (LDLT) for multiple HCCs and hepatitis C cirrhosis is reported. The recipient was a 58-year-old female, and the left lobe living donor was the 30-year-old healthy daughter of the recipient. Three years after LDLT, the patient received 48 weeks of interferon treatment for recurrent hepatitis C with advanced fibrosis. The patient has shown successful viral clearance since then. However, an HCC was recognized in the liver graft during a follow-up computed tomography scan performed 6 years after LDLT, and it was surgically resected. To analyze its origin [either from the patient (metastatic) or from the living donor (de novo)], genotyping by microsatellite analysis of tissue and blood samples from the donor and recipient was performed, and it revealed that the HCC originated from the donor. To the best of our knowledge, this is the first report of de novo HCC in a liver graft with sustained hepatitis C virus clearance after LT for advanced HCCs and hepatitis C cirrhosis.

📜 SIMILAR VOLUMES

Antibodies against cytokeratin 8/18 in a

Antibodies against cytokeratin 8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation

✍ Ayano Inui; Tsuyoshi Sogo; Haruki Komatsu; Hiroshi Miyakawa; Tomoo Fujisawa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Graft dysfunction mimicking autoimmune hepatitis rarely develops after liver transplantation for nonautoimmune disease. The mechanism(s) and causes of de novo autoimmune hepatitis are unknown. We examined autoantibodies serially in a patient with de novo autoimmune hepatitis and in patients without

Histologic recurrence of chronic hepatit

Histologic recurrence of chronic hepatitis C virus in patients after living donor and deceased donor liver transplantation

✍ Mitchell L. Shiffman; R. Todd Stravitz; Melissa J. Contos; A. Scott Mills; Richa 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 112 KB 👁 2 views

Hepatitis C virus (HCV) recurs in nearly all patients after liver transplantation. This recurrence is associated with progressive fibrosis and graft loss. It remains unclear whether the natural course of HCV recurrence is altered in patients who undergo living donor liver transplantation (LDLT). We

Spontaneous clearance of hepatitis C vir

Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus

✍ Vishal Bhagat; Julie A. Foont; Eugene R. Schiff; Arie Regev 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

Spontaneous resolution of chronic hepatitis C virus (HCV) infection is exceedingly rare and poorly understood. As HCV and human immunodeficiency virus (HIV) have shared routes of transmission, HCV coinfection is estimated to affect 15%-30% of the HIV-positive population. We report 2 patients with HC